CN8 A/S: Financial statements 2023
CVR: 42822604
Source: annual report 2023, Danish Business Authority
01/10/2022 – 30/09/2023
CN8 A/S (CVR 42822604) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -36,075 and a net result of DKK -28,046 compared with DKK -9,991 the year before. Equity in the 2023 report amounted to DKK 1,963. The solvency ratio was 4.5%.
- Gross Profit
- DKK -36,075
- Profit/Loss
- DKK -28,046
- Equity
- DKK 1,963
- Total Assets
- DKK 43,213
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -36 t. | -28 t. | 2 t. | - |
| 2022 | - | -13 t. | -10 t. | 30 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationAbout CN8 A/S
CN8 A/S is a Danish company of the type Aktieselskab based in Lynge, founded in 2021. The company is registered under the industry Investering for egen regning. The company was previously named TWH VII A/S and TWH VII ApS. The management consists of Lars Nørgaard. The board consists of Julian Tøpholm (chair), Arne Due-Hansen, Adam Westermann and Jan Tøpholm. The company is owned by LUNDBECKFOND INVEST A/S and T&W Medical A/S. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -1,595,000 and a net result of DKK 21,695,000 compared with DKK 20,527,000 the year before. Equity in the 2025 report amounted to DKK 7,566,544,000.